News archive for 2022 | www.emcdda.europa.eu

asphalt road with yellow arrows and years 2022, 2023 and 2024

Major changes ahead for EMCDDA as it embarks on new work programme

I am proud to introduce today the EMCDDA’s Single Programming Document (SPD) for the period 2022–2024. This new programming period starts at a time when the COVID-19 pandemic is still unfolding. And...

France takes over EU presidency with the motto ‘Recovery, strength and a sense of belonging’

This month, France took over the rotating presidency of the Council of the EU with the motto ‘Recovery, strength and a sense of belonging’. Over the next six months, the country will lead work at all...

photo of coloured pencils forming a circle

EMCDDA launches PLATO e-learning platform and virtual community of practice

On International Day of Education, we are pleased to announce the launch of PLATO, the EMCDDA’s new e-learning platform, following a successful six-month pilot phase in 2021. The first e-learning...

Latest European Web Survey on Drugs finds cannabis and ecstasy use most impacted by COVID-19

New survey results released today by the EU drugs agency (EMCDDA) reveal that cannabis and ecstasy use are the drug-consumption patterns most impacted by COVID-19 restrictions (1). The European Web...

photo of the building of the emcdda

European Commission proposes stronger mandate for EU drugs agency

The European Commission has proposed today to strengthen the EMCDDA's mandate to ensure that the agency plays a more important role in identifying and addressing current and future challenges related...

Loading